Objective:

To evaluate the association between disease severity, itch-related measures, and quality of life (QoL) in patients with chronic inflammatory skin diseases.

Approach:

• Study Design: A prospective, cross-sectional study involving 522 adult patients with chronic pruritus from various dermatology practices in Germany.
• Assessment Methods: Dermatologists assessed disease severity using disease-specific instruments; patients completed validated questionnaires on itch intensity, duration, scratching frequency, sleep disturbance, and QoL.
• Data Analysis: Multivariable regression and mediation analyses were performed to explore the relationships between disease severity, itch-related measures, and QoL.

Key Findings:

• Daily itch duration was the strongest mediator between disease severity and QoL.
• Sleep disturbance, scratching frequency, and average itch intensity also mediated the relationship, while worst itch intensity did not.
• Impaired QoL correlated more strongly with itch-related measures than with overall disease severity.
• Female sex, moderate disease severity, scratching frequency, and sleep disturbance were independently associated with greater QoL impairment.
• Patients with atopic dermatitis, chronic prurigo, and chronic urticaria experienced higher QoL impairment compared to those with psoriasis.

Interpretation:

Limitations:

• Cross-sectional design limits causal inference.
• Disease severity was harmonized using a composite measure.
• Chronic urticaria severity was assessed with a nonvalidated tool.
• Patient groups were unequal in size.
• Findings may not be generalizable to pediatric populations.

Conclusion:

Sources:

• Dermatology and Therapy